Archive - The Caseload

Oscar's S-1: Why It Matters

There's more to this business than $400 million in losses

Feb 7, 2021 •

Steve Hardgrove

January 2021

Accolade buys 2nd.MD; Point Solutions and Platforms

Making Fee For Service Work Better

Jan 30, 2021 •

Steve Hardgrove

October 2020

Cash-Pay Potential, Insurance Shortcomings

Putting GoodRx and Sesame into a broader context

Oct 20, 2020 •

Steve Hardgrove

September 2020

GoodRx's S-1, How PBMs Work, Another Telemedicine integration

This is how you get 40% EBITDA margins

Sep 10, 2020 •

Steve Hardgrove

July 2020

Blue Cross North Carolina, ACOs, Aledade, Bright Health, Comparing Value Chains

An insurance company makes an offer that independent practices can't refuse

Jul 2, 2020 •

Steve Hardgrove

June 2020

March 2020

Coronavirus Look Ahead

What are we in for?

Mar 15, 2020 •

Steve Hardgrove

The Upside-Down Insurance Incentive

The insurance industry does well when their costs go up?

Mar 5, 2020 •

Steve Hardgrove

February 2020

Radically Different and Fundamentally Lower

EQRx, a biotech startup, launches with bold ambitions to reduce drug prices. How will they do it?

Feb 12, 2020 •

Steve Hardgrove

January 2020

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts